(Q42673998)

4 November 2017

title

Assessment of efficacy and safety of FK778 in comparison with standard care in renal transplant recipients with untreated BK nephropathy (English)

1 reference

4 November 2017

Assessment of Efficacy and Safety of FK778 in Comparison With Standard Care in Renal Transplant Recipients With Untreated BK Nephropathy (English)

1 reference

https://api.crossref.org/works/10.1097/TP.0B013E3181F2C94B

5 July 2024

3

E Steve Woodle

1 reference

4 November 2017

Antonio Guasch

1

1 reference

4 November 2017

Prabir Roy-Chaudhury

2

1 reference

4 November 2017

William Fitzsimmons

4

1 reference

4 November 2017

John Holman

5

1 reference

4 November 2017

FK778 BK Nephropathy Study Group

7

1 reference

4 November 2017

E. Steve Woodle

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20811320

5 July 2024

M. Roy First

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20811320

5 July 2024

language of work or name

English

0 references

publication date

1 October 2010

1 reference

4 November 2017

27 October 2010

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20811320

full work available at URL

5 July 2024

http://journals.lww.com/00007890-201010270-00014

1 reference

https://api.crossref.org/works/10.1097/TP.0B013E3181F2C94B

5 July 2024

1 reference

4 November 2017

volume

90

1 reference

4 November 2017

issue

8

1 reference

4 November 2017

page(s)

891-897

1 reference

BK virus nephritis after renal transplantation

4 November 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1097/TP.0B013E3181F2C94B

Polyomavirus-associated nephropathy: update of clinical management in kidney transplant patients

5 July 2024

2

1 reference

https://api.crossref.org/works/10.1097/TP.0B013E3181F2C94B

The decade of polyomavirus BK-associated nephropathy: state of affairs

5 July 2024

4

1 reference

https://api.crossref.org/works/10.1097/TP.0B013E3181F2C94B

Influence of surveillance renal allograft biopsy on diagnosis and prognosis of polyomavirus-associated nephropathy

5 July 2024

5

1 reference

https://api.crossref.org/works/10.1097/TP.0B013E3181F2C94B

Seroepidemiology of the human polyomaviruses

5 July 2024

6

1 reference

https://api.crossref.org/works/10.1097/TP.0B013E3181F2C94B

Risk factors for polyoma virus nephropathy

5 July 2024

7

1 reference

https://api.crossref.org/works/10.1097/TP.0B013E3181F2C94B

Successful treatment of BK viremia using reduction in immunosuppression without antiviral therapy

5 July 2024

9

1 reference

https://api.crossref.org/works/10.1097/TP.0B013E3181F2C94B

Kidney transplant function and histological clearance of virus following diagnosis of polyomavirus-associated nephropathy (PVAN).

5 July 2024

10

1 reference

https://api.crossref.org/works/10.1097/TP.0B013E3181F2C94B

Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction

5 July 2024

11

1 reference

https://api.crossref.org/works/10.1097/TP.0B013E3181F2C94B

Polyomavirus nephropathy after renal transplantation: a single centre experience

5 July 2024

12

1 reference

https://api.crossref.org/works/10.1097/TP.0B013E3181F2C94B

BK virus nephritis: risk factors, timing, and outcome in renal transplant recipients.

5 July 2024

13

1 reference

https://api.crossref.org/works/10.1097/TP.0B013E3181F2C94B

Leflunomide for polyomavirus type BK nephropathy

5 July 2024

14

1 reference

https://api.crossref.org/works/10.1097/TP.0B013E3181F2C94B

Treatment of renal allograft polyoma BK virus infection with leflunomide

5 July 2024

15

1 reference

https://api.crossref.org/works/10.1097/TP.0B013E3181F2C94B

Effect of leflunomide and cidofovir on replication of BK virus in an in vitro culture system

5 July 2024

16

1 reference

https://api.crossref.org/works/10.1097/TP.0B013E3181F2C94B

Inhibition of cytomegalovirus in vitro and in vivo by the experimental immunosuppressive agent leflunomide

5 July 2024

17

1 reference

https://api.crossref.org/works/10.1097/TP.0B013E3181F2C94B

Leflunomide treatment for polyomavirus BK-associated nephropathy after kidney transplantation

5 July 2024

18

1 reference

https://api.crossref.org/works/10.1097/TP.0B013E3181F2C94B

Development of a novel drug for transplantation: current results and future perspectives

5 July 2024

19

1 reference

https://api.crossref.org/works/10.1097/TP.0B013E3181F2C94B

Mechanistic study of malononitrileamide FK778 in cardiac transplantation and CMV infection in rats

5 July 2024

20

1 reference

https://api.crossref.org/works/10.1097/TP.0B013E3181F2C94B

Inhibition of human cytomegalovirus signaling and replication by the immunosuppressant FK778.

5 July 2024

21

1 reference

https://api.crossref.org/works/10.1097/TP.0B013E3181F2C94B

The effects of FK778 in combination with tacrolimus and steroids: a phase II multicenter study in renal transplant patients

5 July 2024

22

1 reference

https://api.crossref.org/works/10.1097/TP.0B013E3181F2C94B

Treatment of polyomavirus infection in kidney transplant recipients: a systematic review.

5 July 2024

23

1 reference

https://api.crossref.org/works/10.1097/TP.0B013E3181F2C94B

BK virus nephritis after renal transplantation

5 July 2024

24

1 reference

https://api.crossref.org/works/10.1097/TP.0B013E3181F2C94B

Higher levels of leflunomide are associated with hemolysis and are not superior to lower levels for BK virus clearance in renal transplant patients

5 July 2024

25

1 reference

https://api.crossref.org/works/10.1097/TP.0B013E3181F2C94B

5 July 2024

Identifiers

1 reference

4 November 2017

1 reference